Contineum Therapeutics, Inc. (CTNM)
9.86
+0.08
(+0.82%)
USD |
NASDAQ |
Nov 13, 16:00
9.885
+0.02
(+0.25%)
After-Hours: 19:59
Contineum Therapeutics Market Cap : 387.00M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 387.00M |
| November 12, 2026 | 383.86M |
| November 11, 2026 | 422.72M |
| November 10, 2026 | 414.47M |
| November 09, 2026 | 404.27M |
| November 06, 2026 | 373.66M |
| November 05, 2026 | 345.79M |
| November 04, 2026 | 384.25M |
| November 03, 2026 | 380.33M |
| November 02, 2026 | 375.23M |
| October 30, 2026 | 368.55M |
| October 29, 2026 | 350.93M |
| October 28, 2026 | 344.16M |
| October 27, 2026 | 338.14M |
| October 26, 2026 | 306.17M |
| October 23, 2026 | 312.57M |
| October 22, 2026 | 315.76M |
| October 21, 2026 | 314.07M |
| October 20, 2026 | 318.21M |
| October 19, 2026 | 279.84M |
| October 16, 2026 | 266.30M |
| October 15, 2026 | 297.15M |
| October 14, 2026 | 306.17M |
| October 13, 2026 | 316.70M |
| October 12, 2026 | 322.16M |
| Date | Value |
|---|---|
| October 09, 2026 | 503.27M |
| October 08, 2026 | 495.74M |
| October 07, 2026 | 478.82M |
| October 06, 2026 | 475.81M |
| October 05, 2026 | 478.44M |
| October 02, 2026 | 493.49M |
| October 01, 2026 | 488.60M |
| September 30, 2026 | 504.77M |
| September 29, 2026 | 432.55M |
| September 28, 2026 | 478.82M |
| September 25, 2026 | 472.42M |
| September 24, 2026 | 469.79M |
| September 23, 2026 | 470.54M |
| September 22, 2026 | 504.02M |
| September 21, 2026 | 509.66M |
| September 18, 2026 | 508.91M |
| September 17, 2026 | 496.87M |
| September 16, 2026 | 517.56M |
| September 15, 2026 | 519.82M |
| September 14, 2026 | 557.43M |
| September 11, 2026 | 557.43M |
| September 10, 2026 | 551.41M |
| September 09, 2026 | 569.47M |
| September 08, 2026 | 599.56M |
| September 04, 2026 | 628.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 13.51M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| GB Sciences, Inc. | 0.0407M |
| Arvinas, Inc. | 446.71M |
| Fulcrum Therapeutics, Inc. | 287.60M |
Market Cap Related Metrics
| Price to Book Value | 1.577 |
| Price | 9.86 |
| Earnings Yield | -17.95% |